Clinical Trials Logo

Glucose, Low Blood clinical trials

View clinical trials related to Glucose, Low Blood.

Filter by:
  • None
  • Page 1

NCT ID: NCT05369247 Completed - Pregnancy Related Clinical Trials

Interval Versus Continuous Exercise During Pregnancy

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

The objective of this randomized cross-over design was to investigate the fetal well-being and maternal glycemic response to an acute bout of aerobic high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT) with pregnant individuals.

NCT ID: NCT04648397 Completed - Glucose, High Blood Clinical Trials

The Effect of Chewing Duration on Blood Glucose Levels

Start date: November 16, 2020
Phase: N/A
Study type: Interventional

This study aims to assess the impact of speed of consumption of two starch-based foods varying in fibre content on blood glucose levels in normal healthy subjects. Furthermore, the mediating roles of salivary amylase and particle size on blood glucose levels will be studied. The study has a randomized cross-over design. Subjects consume two test-lunches (chick peas and brown rice) in duplicate on 8 different test days, at either long or short chewing duration. Glucose responses will be monitored via a continuous glucose monitoring device and expectorated boluses will be collected during each test day for assessments of amylase activity and food particle size.

NCT ID: NCT04230694 Enrolling by invitation - Diabetes Clinical Trials

Continuous Glucose Monitoring of Hospitalized Patients With Diabetes

Start date: September 20, 2021
Phase: N/A
Study type: Interventional

Systematic continuous glucose monitoring (CGM) is commonly provided as a treatment option to patients with diabetes in ambulatory care settings yet is rarely provided during hospitalization. CGM of inpatients has the potential to be the care delivery innovation that is feasible, cost effective and can improve glucose control, especially by reducing hypoglycemic events. Studies of CGM use in the ICU setting have been found to be helpful for reducing hypoglycemia in some studies while less so in others, however, these studies were performed with earlier generation glucose monitoring devices(5). ICU studies have confirmed accuracy of CGM measurements compared with capillary glucose even in settings with use of vasopressors and large-volume resuscitation. A limited number of studies have evaluated glycemic outcomes in the inpatient non-ICU setting. Studies of non-ICU patients (6-10) are limited by very small sample size, short study duration, and use of older CGM devices. There is, therefore, a critical need to systematically investigate the use of CGM in the inpatient care of patients with diabetes mellitus who are receiving care in a hospital setting that is typical of inpatient care.

NCT ID: NCT04159948 Recruiting - Fasting Clinical Trials

Preoperative Carbohydrate Drink Prior to Elective Caesarean Section

Start date: January 20, 2020
Phase: N/A
Study type: Interventional

Prior to caesarean section, patients should fast from solid food for 6 hours and from clear fluids for 2 hours. Carbohydrate drinks can also be consumed up to 2 hours before surgery. These drinks have been shown to improve patient well-being after surgery and may potentially improve the neonatal blood glucose level after delivery and reduce the risk of a low blood glucose level. This study aims to assess the influence of pre-operative carbohydrate drinks on blood glucose levels of the baby at delivery.

NCT ID: NCT03708939 Completed - Glucose Intolerance Clinical Trials

Microbiome and Non-caloric Sweeteners in Humans

Start date: February 19, 2017
Phase: N/A
Study type: Interventional

Non-caloric sweeteners are common food supplements consumed by millions worldwide as means of combating weight gain and diabetes, by retaining sweet taste without increasing caloric intake. While they are considered safe, there is increasing debate regarding their potential role in contributing to metabolic derangements in some humans. The investigators recently demonstrated that non-caloric sweeteners consumption could induce glucose intolerance in mice and, in preliminary experiments, in distinct human subsets, by functionally altering the gut microbiome, and that the gut microbiome plays an important role in mediating differential glucose responses to identical foods. The proportion of the human population that is susceptible to glucose intolerance induced by non-caloric sweeteners, the common factors that are shared between these individuals and whether and how the microbiome promotes the metabolic derangements remain to be addressed.

NCT ID: NCT03428295 Suspended - Glucose, High Blood Clinical Trials

Dose Safety Hybrid Closed Loop and Fully Automated Closed Loop Artificial Pancreas Device in CRC

Start date: June 22, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

The objective of this study is to test two different operating modes of the latest version of the Dose Safety artificial pancreas system (APS), the Dose Safety Controller (DSC version 2.3), in a population of subjects with type 1 diabetes (TID) in a hospital CRC setting. The first mode is the Fully Automated Closed Loop (FACL) mode, in which all insulin delivery is directed by the controller and the second mode is the Hybrid Closed Loop (HCL) mode, in which insulin delivery is a hybrid between controller directed delivery and user directed insulin delivery. There will be two study arms: HCL and FACL. No comparisons will be made between the two arms.

NCT ID: NCT03346746 Completed - Mood Clinical Trials

Utilizing GI: Exploring an Optimum Glycaemic Profile for Cognitive Function Across the Day

Start date: February 1, 2017
Phase: N/A
Study type: Interventional

This study provides participants with two diets that vary in their glycaemic index values (low vs. high), whilst also measuring cognitive performance and mood.

NCT ID: NCT03344185 Completed - Mood Clinical Trials

The Effect of Glycaemic Index Variation on Blood Glucose and Mood in Healthy Participants Across the Day

Start date: July 2016
Phase: N/A
Study type: Interventional

This study provided 24 healthy subjects with two diets that varied in their glycaemic index values. One condition was a low GI diet, whilst the other was a high GI diet. Glucose concentrations and mood were measured throughout each test day.

NCT ID: NCT03252704 Completed - Glucose, High Blood Clinical Trials

Post-prandial Glycemic Response to Fiber in Healthy Adults

Start date: March 31, 2016
Phase: N/A
Study type: Interventional

This randomized, double-blind, comparator controlled trial evaluated the blood glucose and insulin responses in healthy adults, after consuming a high fiber or low fiber muffin top.